Professional Reference articles are designed for health professionals to use. They are written by UK doctors and based on research evidence, UK and European Guidelines. You may find one of our health articles more useful.
Treatment of almost all medical conditions has been affected by the COVID-19 pandemic. NICE has issued rapid update guidelines in relation to many of these. This guidance is changing frequently. Please visit https://www.nice.org.uk/covid-19 to see if there is temporary guidance issued by NICE in relation to the management of this condition, which may vary from the information given below.
Nightmares can be defined as vivid and terrifying dreams which awaken the dreamer from sleep. Typically, the dreamer wakes from the rapid eye movement (REM) stage of sleep and can remember a detailed, perhaps bizarre dream plot. There is evidence that frequent nightmares are associated with insomnia and poor-quality sleep.
Although such dreams are part of normal human experience, for some they can be a recurrent and extremely troubling problem. This is particularly so for young children but they can be disruptive to the whole family. Explanation and reassurance are often helpful particularly for parents who can then in turn be more reassuring to the affected child.
It is important to distinguish nightmare disorder from night terrors (which are episodes of panic and confusion, with difficulty waking or bringing to awareness, and of which the sufferer has no recollection). The ICD-10 definition of the diagnosis of a nightmare disorder is detailed below:
ICD-10 definition of the diagnosis of a nightmare disorder
A sleep disorder characterised by the repeated occurrence of frightening dreams which precipitate awakenings from sleep; on awakening, the individual becomes fully alert and oriented and has detailed recall of the nightmare, which usually involves imminent danger or extreme embarrassment to the individual.
Nightmares are common, particularly in children.
- 10-50% of those aged 3-6 years are estimated to suffer from nightmares that disturb their sleep, or that of their parents.
- They normally start between the ages of 2-5 years.
- A cross-sectional study of 4- to 12-year-olds suggests a peak prevalence between 7 and 9 years, with 87% and 95.7% of children retrospectively reporting bad dreams often or sometimes.
- A literature review reports that up to 85% of adults report at least one nightmare within the previous year, 8-29% report monthly nightmares and 2-6% report weekly nightmares.
- Older people were 20-50% less likely to have nightmares than young people.
- Nightmares are associated with a range of psychiatric symptoms, full-blown psychiatric disorders such as post-traumatic stress disorder (PTSD) and sleep disturbances. While some psychiatric, personality, sleep and biological correlates of nightmares have been described, the vast majority of extant studies are cross-sectional, precluding conclusive determination of causality and etiology. Traumatic events, waking psychological distress, or sleep disturbance may contribute to the onset and maintenance of nightmares. The results of longitutidnal studies are awaited but in the meantime current thinking on the aetiology of nightmares is briefly summarised below:
- Usually there is no underlying pathology.
- It is thought that PTSD, sleep disturbance and psychological stress may contribute.
- Nightmares may (rarely) be a symptom of a more serious psychiatric disorder such as borderline personality disorder.
- Twin studies suggest that genetic factors may be involved.
- A link with suicidality has been suggested.
- One study of children viewing images depicting fantastic or real entities and situations revealed that children with nighttime fears demonstrated more fantasy-reality confusion compared to their controls.
- Many medications are reported to increase nightmares:
- Beta-blockers (the water-soluble beta-blockers such as atenolol are less likely to cause nightmares, as they are less likely to cross the blood-brain barrier).
- Centrally acting antihypertensives.
- Antidepressants: selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants and monoamine-oxidase inhibitors( MAOIs).
- Anti-Parkinsonian agents: levodopa, selegiline.
- Short-acting barbiturates
- Rauwolfia alkaloids
- Medication withdrawal: benzodiazepine or alcohol withdrawal leads to a rebound of REM sleep which may increase nightmares.
- Nightmares tend to start in the latter half of the sleep cycle, during REM sleep.
- The nightmare usually involves a threat of danger. This may be a physical threat such as being pursued, or a psychological one such as being teased. Frequent threatening characters for children are monsters, ferocious animals, ghosts, bullies or 'bad' people.
- It is unusual for the person to shout out, move or have autonomic disturbance during the experience, although these things may occur to a minor degree.
- When awoken it is usual for the person to be orientated, alert and responsive and to be receptive to calming by their parents/others. The details of the dream are usually remembered. This contrasts with night terrors where the person may be difficult to rouse and may not recall what has been troubling them.
- There may be a family history of similar problems.
- Take a careful history, preferably also from parents, carers or relatives who have witnessed the event.
- Assess whether mental impairment, mental illness, depression, other central nervous system (CNS) disease or a febrile illness could be contributing.
- Consider medication history and alcohol/benzodiazepine withdrawal.
- Ask if there has been any recent traumatic event or conflict/stress.
- Night terrors - the difference from nightmares is that: they tend to occur earlier rather than later during the night; the person may initially be unresponsive or disorientated; unlike nightmares, they usually cannot recall the event; signs of autonomic arousal such as dilated pupils, tachypnoea and tachycardia are more likely. See related separate article Night Terrors and Parasomnias.
- Underlying organic brain disorder - eg, delirium or mental impairment.
- Post-traumatic stress disorder (PTSD): nightmares are a feature of PTSD. However, in PTSD the dream content often involves reliving the trauma and there are other symptoms such as poor sleep and daytime anxiety.
- Medication or withdrawal from medication.
- Recurrent febrile illness causing delirium or predisposing to nightmares (this may also cause night terrors).
- Depressive illness with melancholic features may be associated in adults.
- REM sleep behaviour disorder (a problem affecting particularly older adults).
Investigations are not usually necessary if the diagnosis is clear from the history. However, bear in mind that:
- Night terrors (sleep terrors) and sleepwalking (which differ from nightmares, as explained above) have been linked to physical sleep disorders such as obstructive sleep apnoea and other types of sleep disordered breathing.If these problems are suspected, or the diagnosis is unclear, assessment at a sleep clinic may help.
- If there is reason to suspect an underlying cause then electroencephalogram (EEG), blood tests and CNS imaging may be considered.
- Reassurance of the patient or child and parents is all that is usually required.
- Helpful tips for children:
- It may help to develop a relaxing bedtime routine that does not vary. Attention to causes of stress and upheaval within the home may help reduce the propensity to nightmares.
- Use of night lights and other strategies that may reduce a child's anxiety levels at night can help.
- If the nightmare is recurrent then it may help for the parents to talk through the nightmare and imagine a less scary ending.
- If the problem is occurring, say, on a more than twice-weekly basis persistently, then it may be worth referring for psychological or child-psychiatric input.
- Cognitive behavioural therapy may be beneficial.
- There is evidence that psychological techniques such as imaginal confrontation with nightmare contents or imagery re-scripting and rehearsal may be helpful.
- Drug treatment is not usually helpful and is more likely to cause nightmares. (This contrasts with some other types of sleep disorder, where medication may help.) However, in persistent cases, an REM-suppressant drug such as a tricyclic antidepressant may be helpful.
- Prazosin may be helpful for nightmares associated with PTSD but further research is required.
The prognosis is very good. The symptoms should resolve as time passes and after reassurance of the child and parents that this is a relatively normal experience for some young children. If the symptoms persist beyond the age of 6, consideration should be given to underlying conditions such as anxiety disorders, affective distress or PTSD.
Further reading and references
Marinova P, Koychev I, Laleva L, et al; Nightmares and suicide: predicting risk in depression. Psychiatr Danub. 2014 Jun26(2):159-64.
Godin I, Montplaisir J, Gagnon JF, et al; Alexithymia associated with nightmare distress in idiopathic REM sleep behavior disorder. Sleep. 2013 Dec 136(12):1957-62. doi: 10.5665/sleep.3238.
Simor P, Bodizs R, Horvath K, et al; Disturbed dreaming and the instability of sleep: altered nonrapid eye movement sleep microstructure in individuals with frequent nightmares as revealed by the cyclic alternating pattern. Sleep. 2013 Mar 136(3):413-9. doi: 10.5665/sleep.2462.
Nightmare disorder; ICD-10data.com, 2014.
Shneerson, J; Sleep Medicine: A Guide to Sleep and its Disorders, 2009
Simard V, Nielsen TA, Tremblay RE, et al; Longitudinal study of bad dreams in preschool-aged children: prevalence, demographic correlates, risk and protective factors. Sleep. 2008 Jan31(1):62-70.
Hasler B, Germain A; Correlates and Treatments of Nightmares in Adults. Sleep Med Clin. 2009 Dec4(4):507-517.
Semiz UB, Basoglu C, Ebrinc S, et al; Nightmare disorder, dream anxiety, and subjective sleep quality in patients with borderline personality disorder. Psychiatry Clin Neurosci. 2008 Feb62(1):48-55. doi: 10.1111/j.1440-1819.2007.01789.x.
Zisenwine T, Kaplan M, Kushnir J, et al; Nighttime fears and fantasy-reality differentiation in preschool children. Child Psychiatry Hum Dev. 2013 Feb44(1):186-99. doi: 10.1007/s10578-012-0318-x.
Markov D, Jaffe F, Doghramji K; Update on parasomnias: a review for psychiatric practice. Psychiatry (Edgmont). 2006 Jul3(7):69-76.
Pagel JF; Nightmares and disorders of dreaming. Am Fam Physician. 2000 Apr 161(7):2037-42, 2044.
Blagrove M, Morgan CJ, Curran HV, et al; The incidence of unpleasant dreams after sub-anaesthetic ketamine. Psychopharmacology (Berl). 2009 Mar203(1):109-20. doi: 10.1007/s00213-008-1377-3. Epub 2008 Oct 24.
Eiser AS; Dream disorders and treatment. Curr Treat Options Neurol. 2007 Sep9(5):317-24.
Bryant R; Post-traumatic stress disorder vs traumatic brain injury. Dialogues Clin Neurosci. 201113(3):251-62.
Aurora RN, Zak RS, Auerbach SH, et al; Best practice guide for the treatment of nightmare disorder in adults. J Clin Sleep Med. 2010 Aug 156(4):389-401.
Delirium; NICE Clinical Guideline (July 2010 - last updated March 2019)
Silvestri R, Bromfield E; Recurrent nightmares and disorders of arousal in temporal lobe epilepsy. Brain Res Bull. 2004 Jun 3063(5):369-76.
Nakajima S, Inoue Y, Sasai T, et al; Impact of frequency of nightmares comorbid with insomnia on depression in Japanese rural community residents: a cross-sectional study. Sleep Med. 2014 Mar15(3):371-4. doi: 10.1016/j.sleep.2013.11.785. Epub 2014 Jan 31.
Trotti LM; REM sleep behaviour disorder in older individuals: epidemiology, pathophysiology and management. Drugs Aging. 2010 Jun 127(6):457-70. doi: 10.2165/11536260-000000000-00000.
Chang SJ, Chae KY; Obstructive sleep apnea syndrome in children: Epidemiology, pathophysiology, diagnosis and sequelae. Korean J Pediatr. 2010 Oct53(10):863-71. doi: 10.3345/kjp.2010.53.10.863. Epub 2010 Oct 31.
Moore M, Allison D, Rosen CL; A review of pediatric nonrespiratory sleep disorders. Chest. 2006 Oct130(4):1252-62.
Hansen K, Hofling V, Kroner-Borowik T, et al; Efficacy of psychological interventions aiming to reduce chronic nightmares: a meta-analysis. Clin Psychol Rev. 2013 Feb33(1):146-55. doi: 10.1016/j.cpr.2012.10.012. Epub 2012 Nov 7.
Kung S, Espinel Z, Lapid MI; Treatment of nightmares with prazosin: a systematic review. Mayo Clin Proc. 2012 Sep87(9):890-900. doi: 10.1016/j.mayocp.2012.05.015. Epub 2012 Aug 9.
Moturi S, Avis K; Assessment and treatment of common pediatric sleep disorders. Psychiatry (Edgmont). 2010 Jun7(6):24-37.